Name | Number of supported studies | Average coverage | |
---|---|---|---|
cardiac muscle cell | 5 studies | 24% ± 4% | |
smooth muscle cell | 4 studies | 21% ± 4% |
Insufficient scRNA-seq data for expression of ASB2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 95% | 3548.12 | 161 / 170 | 85% | 13.64 | 389 / 459 |
prostate | 79% | 2305.70 | 193 / 245 | 96% | 9.40 | 484 / 502 |
intestine | 84% | 5843.74 | 816 / 966 | 72% | 3.09 | 382 / 527 |
bladder | 86% | 4434.29 | 18 / 21 | 67% | 3.59 | 337 / 504 |
esophagus | 67% | 3672.53 | 966 / 1445 | 77% | 3.95 | 140 / 183 |
stomach | 44% | 2076.09 | 157 / 359 | 75% | 6.83 | 214 / 286 |
lymph node | 0% | 0 | 0 / 0 | 100% | 39.61 | 29 / 29 |
muscle | 100% | 34614.58 | 803 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 11.86 | 44 / 45 |
blood vessel | 94% | 2918.73 | 1253 / 1335 | 0% | 0 | 0 / 0 |
heart | 94% | 6240.10 | 807 / 861 | 0% | 0 | 0 / 0 |
skin | 1% | 55.60 | 20 / 1809 | 92% | 7.51 | 434 / 472 |
lung | 10% | 120.83 | 58 / 578 | 82% | 4.39 | 943 / 1155 |
pancreas | 0% | 0 | 0 / 328 | 65% | 2.98 | 115 / 178 |
ovary | 13% | 261.63 | 23 / 180 | 47% | 1.12 | 201 / 430 |
kidney | 1% | 12.55 | 1 / 89 | 58% | 1.73 | 526 / 901 |
eye | 0% | 0 | 0 / 0 | 54% | 1.27 | 43 / 80 |
breast | 3% | 36.32 | 14 / 459 | 43% | 1.06 | 486 / 1118 |
thymus | 3% | 44.52 | 21 / 653 | 34% | 0.90 | 203 / 605 |
spleen | 31% | 319.10 | 75 / 241 | 0% | 0 | 0 / 0 |
brain | 7% | 76.47 | 188 / 2642 | 23% | 0.67 | 164 / 705 |
adrenal gland | 0% | 3.28 | 1 / 258 | 21% | 0.46 | 48 / 230 |
liver | 0% | 0 | 0 / 226 | 21% | 0.53 | 85 / 406 |
peripheral blood | 14% | 502.96 | 133 / 929 | 0% | 0 | 0 / 0 |
adipose | 10% | 141.94 | 121 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0055007 | Biological process | cardiac muscle cell differentiation |
GO_0001947 | Biological process | heart looping |
GO_0055013 | Biological process | cardiac muscle cell development |
GO_0007165 | Biological process | signal transduction |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0036336 | Biological process | dendritic cell migration |
GO_0071800 | Biological process | podosome assembly |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0035914 | Biological process | skeletal muscle cell differentiation |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0030018 | Cellular component | Z disc |
GO_0001725 | Cellular component | stress fiber |
GO_0005829 | Cellular component | cytosol |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0097602 | Molecular function | cullin family protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ASB2 |
Protein name | Ankyrin repeat and SOCS box containing 2 (Ankyrin repeat and SOCS box protein 2) Ankyrin repeat and SOCS box protein 2 (ASB-2) |
Synonyms | |
Description | FUNCTION: Substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins . Mediates Notch-induced ubiquitination and degradation of substrates including TCF3/E2A and JAK2 . Required during embryonic heart development for complete heart looping (By similarity). Required for cardiomyocyte differentiation . .; FUNCTION: [Isoform 1]: Involved in myogenic differentiation and targets filamin FLNB for proteasomal degradation but not filamin FLNA . Also targets DES for proteasomal degradation (By similarity). Acts as a negative regulator of skeletal muscle mass (By similarity). .; FUNCTION: [Isoform 2]: Targets filamins FLNA and FLNB for proteasomal degradation . This leads to enhanced adhesion of hematopoietic cells to fibronectin . Required for FLNA degradation in immature cardiomyocytes which is necessary for actin cytoskeleton remodeling, leading to proper organization of myofibrils and function of mature cardiomyocytes (By similarity). Required for degradation of FLNA and FLNB in immature dendritic cells (DC) which enhances immature DC migration by promoting DC podosome formation and DC-mediated degradation of the extracellular matrix (By similarity). Does not promote proteasomal degradation of tyrosine-protein kinases JAK1 or JAK2 in hematopoietic cells . . |
Accessions | ENST00000555019.6 [Q96Q27-2] Q96Q27 G3V3P8 ENST00000625949.1 ENST00000556062.5 ENST00000628500.1 ENST00000626017.2 ENST00000557613.1 ENST00000555507.5 ENST00000555287.1 G3V4B2 G3V2Z2 G3V484 ENST00000315988.8 [Q96Q27-1] ENST00000629617.2 [Q96Q27-1] ENST00000626296.2 ENST00000612647.3 [Q96Q27-2] |